These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34783525)

  • 21. Rapid in vivo assessment of drug efficacy against Mycobacterium tuberculosis using an improved firefly luciferase.
    Andreu N; Zelmer A; Sampson SL; Ikeh M; Bancroft GJ; Schaible UE; Wiles S; Robertson BD
    J Antimicrob Chemother; 2013 Sep; 68(9):2118-27. PubMed ID: 23633686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The secreted autotransporter toxin (Sat) does not act as a virulence factor in the probiotic Escherichia coli strain Nissle 1917.
    Toloza L; Giménez R; Fábrega MJ; Alvarez CS; Aguilera L; Cañas MA; Martín-Venegas R; Badia J; Baldomà L
    BMC Microbiol; 2015 Oct; 15():250. PubMed ID: 26518156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-inducible remote control of gene expression by probiotic Escherichia coli Nissle 1917 in intestine, tumor and gall bladder of mice.
    Loessner H; Leschner S; Endmann A; Westphal K; Wolf K; Kochruebe K; Miloud T; Altenbuchner J; Weiss S
    Microbes Infect; 2009 Dec; 11(14-15):1097-105. PubMed ID: 19665575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pre- and Neonatal Imprinting on Immunological Homeostasis and Epithelial Barrier Integrity by
    Sarate PJ; Srutkova D; Geissler N; Schwarzer M; Schabussova I; Inic-Kanada A; Kozakova H; Wiedermann U
    Front Immunol; 2020; 11():612775. PubMed ID: 33679699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High density fermentation of probiotic E. coli Nissle 1917 towards heparosan production, characterization, and modification.
    Datta P; Fu L; Brodfuerer P; Dordick JS; Linhardt RJ
    Appl Microbiol Biotechnol; 2021 Feb; 105(3):1051-1062. PubMed ID: 33481068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic engineering of probiotic Escherichia coli Nissle 1917 for clinical application.
    Ou B; Yang Y; Tham WL; Chen L; Guo J; Zhu G
    Appl Microbiol Biotechnol; 2016 Oct; 100(20):8693-9. PubMed ID: 27640192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Escherichia coli Nissle 1917 as safe vehicles for intestinal immune targeted therapy--a review].
    Xia P; Zhu J; Zhu G
    Wei Sheng Wu Xue Bao; 2013 Jun; 53(6):538-44. PubMed ID: 24028055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo bioluminescence imaging of the spatial and temporal colonization of lactobacillus plantarum 423 and enterococcus mundtii ST4SA in the intestinal tract of mice.
    Van Zyl WF; Deane SM; Dicks LMT
    BMC Microbiol; 2018 Oct; 18(1):171. PubMed ID: 30376820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction of a new T7 promoter compatible Escherichia coli Nissle 1917 strain for recombinant production of heme-dependent proteins.
    Fiege K; Frankenberg-Dinkel N
    Microb Cell Fact; 2020 Oct; 19(1):190. PubMed ID: 33023596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Escherichia coli Nissle 1917 Enhances Innate and Adaptive Immune Responses in a Ciprofloxacin-Treated Defined-Microbiota Piglet Model of Human Rotavirus Infection.
    Michael H; Paim FC; Langel SN; Miyazaki A; Fischer DD; Chepngeno J; Amimo J; Deblais L; Rajashekara G; Saif LJ; Vlasova AN
    mSphere; 2021 Mar; 6(2):. PubMed ID: 33789939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decisive role of lipopolysaccharide in activating nitric oxide and cytokine production by the probiotic Escherichia coli strain Nissle 1917.
    Zídek Z; Kmonícková E; Kostecká P; Tlaskalová-Hogenová H
    Folia Microbiol (Praha); 2010 Mar; 55(2):181-9. PubMed ID: 20490762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The role of Escherichia coli strain Nissle 1917 in the gastro-intestinal diseases].
    Różańska D; Regulska-Ilow B; Choroszy-Król I; Ilow R
    Postepy Hig Med Dosw (Online); 2014 Nov; 68():1251-6. PubMed ID: 25380207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancing the Contrast of Tumor Imaging for Image-Guided Surgery Using a Tumor-Targeting Probiotic with the Continuous Expression of a Biomarker.
    Meng T; Ma W; Fan M; Tang W; Duan X
    Anal Chem; 2022 Jul; 94(28):10109-10117. PubMed ID: 35802615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probiotic Escherichia coli Nissle 1917 reduces growth, Shiga toxin expression, release and thus cytotoxicity of enterohemorrhagic Escherichia coli.
    Mohsin M; Guenther S; Schierack P; Tedin K; Wieler LH
    Int J Med Microbiol; 2015 Jan; 305(1):20-6. PubMed ID: 25465158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a Genome-Scale Metabolic Model and Phenome Analysis of the Probiotic
    Kim D; Kim Y; Yoon SH
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672760
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of antibiotic, probiotic, and human rotavirus infection on colonisation dynamics of defined commensal microbiota in a gnotobiotic pig model.
    Huang HC; Vlasova AN; Kumar A; Kandasamy S; Fischer DD; Deblais L; Paim FC; Langel SN; Alhamo MA; Rauf A; Shao L; Saif LJ; Rajashekara G
    Benef Microbes; 2018 Jan; 9(1):71-86. PubMed ID: 29022385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating Brightness and Spectral Properties of Click Beetle and Firefly Luciferases Using Luciferin Analogues: Identification of Preferred Pairings of Luciferase and Substrate for In Vivo Bioluminescence Imaging.
    Zambito G; Gaspar N; Ridwan Y; Hall MP; Shi C; Kirkland TA; Encell LP; Löwik C; Mezzanotte L
    Mol Imaging Biol; 2020 Dec; 22(6):1523-1531. PubMed ID: 32926287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor Colonization and Therapy by
    Gentschev I; Petrov I; Ye M; Kafuri Cifuentes L; Toews R; Cecil A; Oelschaeger TA; Szalay AA
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioluminescence imaging after HSV amplicon vector delivery into brain.
    Pike L; Petravicz J; Wang S
    J Gene Med; 2006 Jul; 8(7):804-13. PubMed ID: 16602134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beneficial effects resulting from oral administration of
    Souza ELS; Campos CLV; Reis DC; Cassali GD; Generoso SV; Cardoso VN; Azevedo V; Medeiros JD; Fernandes GR; Nicoli JR; Martins FS
    Benef Microbes; 2020 Dec; 11(8):779-790. PubMed ID: 33191778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.